Please try another search
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Name | Age | Since | Title |
---|---|---|---|
Martin S. Brown | 59 | 2022 | Director |
Gordon R. Bernard | 71 | 1999 | Chairman of Medical Advisory Board & Independent Director |
A. J. Kazimi | 65 | 1999 | Founder, Chairman, President & CEO |
Timothy Meakin | - | - | Member of Pharmaceutical Advisory Board |
Joseph M. Williams | 66 | - | Member of Pharmaceutical Advisory Board |
Joseph Carpino | - | - | Member of Pharmaceutical Advisory Board |
Robert A. Anderson | 83 | - | Member of Pharmaceutical Advisory Board |
J. William Hix | 76 | - | Member of Pharmaceutical Advisory Board |
David Warrell | - | - | Member of Medical Advisory Board |
Richard C. Dart | - | - | Member of Medical Advisory Board |
Robert Roberts | 82 | - | Member of Medical Advisory Board |
Ben deBoisblanc | - | - | Member of Medical Advisory Board |
Neil M. Richie | - | - | Member of Pharmaceutical Advisory Board |
Caroline R. Young | 49 | 2016 | Independent Director |
Kenneth John Krogulski | 65 | 2017 | Independent Director |
Joseph C. Galante | 73 | 2018 | Independent Director |
James R. Jones | 75 | 2010 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review